Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Janani Rangaswami, MD, FACP, FAHA

Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy, and education relevant to a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.

Janani Rangaswami, MD, FACP, FAHA
Chair, Council on Kidney in Cardiovascular Disease

Mark Your Calendars for Hypertension 2023

September 7–10, 2023
Sheraton Boston Hotel | Boston, Massachusetts
black male doctor

AHA Professional Members are Difference Makers

research

Funding Opportunities

The method for applying for funding is Web-based, using our electronic system, ProposalCentral.


Hypertension Journal cover

Hypertension

Hypertension is one of 14 AHA scientific journals. It represents the Councils on Hypertension and KCVD.


Scientific Sessions 2022

Pre-Sessions Symposia & Early Career Day: November 4
Scientific Sessions: November 5–7
Chicago, Illinois + Virtual